We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Loss of Notch1 Signaling Leads to Skin Cancer in Mouse Model

By LabMedica International staff writers
Posted on 16 Jul 2009
Print article
Researchers using a line of genetically engineered mice lacking the Notch1 signaling protein in some skin cells have found that a state of persistent inflammation can lead to the generation of skin cancers from both normal cells and those lacking the Notch1 gene.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) created a line of mice with both normal and Notch1 null skin cells. These animals developed thickened and inflamed patches of skin due to an increased number of blood vessels and local inflammation, which were a result of missing Notch1 signaling in some of the cells. Interestingly, these animals were prone to developing skin papillomas that originated from both normal and Notch 1 null skin cells. About 10% of these papillomas progressed to basal cell carcinomas.

While Notch1 is generally considered a tumor-suppressing gene in skin cells, Notch1 null patches of skin encouraged angiogenesis and the production of growth factors. The persistent expression of these factors provided cells with nutrients and proliferation signals that promoted tumor formation in the mutant skin tissue and in neighboring normal skin cells with active Notch1 signaling.

"The chronic skin condition in the mice led to the growth of skin tumors," said senior author Dr. Raphael Kopan, professor of developmental biology and dermatology at Washington University School of Medicine. "And what we learned from this process fit very well with the emerging realization that a tumor's surroundings play a critical role in its development. The study suggests that as researchers develop drugs, they should be mindful of their potential effect on the skin, particularly those that cause chronic damage to skin integrity. Studies like ours help define the range of possible complications in drug design and help tailor therapies to avoid them."

"It is very reasonable to assume that chronic wounds in a variety of tissues have similar characteristics," said Dr. Kopan. "The skin of these mice is easy to monitor and will give us the ability to further analyze tumor promotion and find answers that might apply to any chronic wound."

Related Links:

Washington University School of Medicine


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Urine Drug Test
Instant-view Methadone Urine Drug Test
New
Thyroid ELISA Kit
AESKULISA a-TPO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.